European Myeloma Network (EMN) Sample Project

Recruiting now

Conditions studied: Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma, MGUS

In brief

This is an observational, non-interventional, multicenter study for the prospective collection, storage and analysis of patients' biological samples. This study establishes a common international infrastructure useful to collect standard clinical variables at baseline and during treatment and to uniformly collect and store biological samples

Key facts

Study ID

NCT06237803

Run by

European Myeloma Network B.V.

People needed

6000

Starts

2022-12-21

Expected to finish

2037-12-01

Last updated by the study team

2025-12-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with MGUS, smouldering Multiple Myeloma (SMM) , MM (Multiple Myeloma) (+/- EMD), plasma cell leukemia (PCL) (+/- EMD)
• Subjects are ≥ 18 years old.
• Subjects have provided written informed consent in accordance with federal, local, and institutional guidelines prior to initiation of any project-specific activities or procedures.
• Subjects do not have kind of condition that, in the opinion of the Investigators, may compromise the ability of the subjects to give written informed consent and
• subjects are, in the investigator's opinion, willing and able to comply with the protocol requirements.

You may not qualify if…

• Previous treatment with anti-myeloma therapy (excluding one course of therapy in patients in which urgent therapy is deemed necessary according to physician's discretion, e.g. myeloma-related complications resistant to supportive care).
• Subjects have had prior unforeseen (serious) adverse reactions to blood donation including, but not limited to fainting, angina, severe bruising, allergic reactions, or any other adverse events.
• Any psychological, familial, sociological and geographical condition potentially hampering compliance with the protocol and follow-up schedule.

Where it is running

• Alfred Hospital — Melbourne, Australia (enrolling)
• KUK Linz — Linz, Austria (enrolling)
• Medical University Vienna — Vienna, Austria (enrolling)
• Department of Haematology UZ Leuven Gasthuisberg — Leuven, Belgium (enrolling)
• Nemocnice Havířov — Havířov, Czechia (enrolling)
• Nemocnice Nový Jičín — Nový Jičín, Czechia (enrolling)
• Fakultní nemocnice — Olomouc, Czechia (enrolling)
• Slezská nemocnice — Opava, Czechia (enrolling)
• Fakutni nemocnice Ostrava — Ostrava, Czechia (enrolling)
• Nemocnice Pelhrimov — Pelhřimov, Czechia (enrolling)
• Všeobecná Fakultní nemocnice v Praz — Prague, Czechia (enrolling)
• Regional General Hospital Alexandra Dept of Clinical Therapeutics — Athens, Greece (enrolling)
• Theagenion Cancer Hospital — Thessaloniki, Greece (enrolling)
• Beaumont Hospital, Dublin, Hematology Department — Galway, Ireland (enrolling)
• A.O. 'SS. Antonio e Biagio' — Alessandria, Italy (enrolling)
• AOU Ospedali Riuniti di Ancona — Ancona, Italy (enrolling)
• Bari-A.O.U. Consorziale Policlinico - Medicina Interna — Bari, Italy (enrolling)
• Policlinico S Orsola Malpighi — Bologna, Italy (enrolling)
• A.O.Spedali Civili di Brescia — Brescia, Italy (enrolling)
• A.S.U.R. Regione Marche — Civitanova Marche, Italy (enrolling)
• A.O.U. Careggi — Florence, Italy (enrolling)
• A.O.U. Policlinico S. Martino - Clinica Ematologica — Genova, Italy (enrolling)
• A.O.U. Policlinico S. Martino - Ematologia — Genova, Italy (enrolling)
• A.O. 'Cardinale G.Panico' — Lecce, Italy (enrolling)
• A.O. di Rilievo Nazionale A. Cardarelli — Naples, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.